Introduction
============

Infectious diseases caused by pathogenic bacteria have been historically a major cause of human death. The discovery and mass production of antibiotics dramatically reduced the mortality associated to bacterial infections for several years. However, the golden age of antibiotic seems to be over: according to a report led by the economist Jim O'Neill, in 2017 around 700,000 deaths were caused by multi-drug resistant (MDR) bacterial infections. His prediction, however, indicates that by 2,050 the mortality associated to MDR-bacterial infections will be around of 10 million ([@B43]).

Due to this phenomenon, the World Health Organization (WHO) has classified the most concerning MDR-bacteria into different groups of priority according with the urgency to develop new antibiotics and therapies ([@B50]). The critical priority group includes *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Mycobacterium tuberculosis.* Also, different species of the *Enterobacteriaceae* genus, including *Klebsiella pneumoniae*, *Escherichia coli*, are part of this group. The high priority group includes the pathogenic bacteria *Staphylococcus aureus*, *Neisseria gonorrhoeae*, *Salmonella* spp., among others.

In a previous report we discussed the relevance of the anti-inflammatory cytokine Interleukin-10 (IL-10) in the immunity against different pathogenic bacteria ([@B45]). We conclude that IL-10 production is required for host survival during infections caused by extracellular and/or highly pro-inflammatory bacteria, including *Streptococcus pneumoniae*, *Pseudomonas aeruginosa*, *Francisella tularensis*, *Escherichia coli*, and *Mycobacterium tuberculosis* ([@B45]). On the other hand, IL-10 production impairs host survival during infections caused by intracellular bacteria or bacterial pathogens that modulate the inflammatory response, such as *Klebsiella pneumoniae*, *Bordetella pertussis*, *Listeria monocytogenes*, *Brucella abortus* and *Salmonella enterica* serovar Typhimurium ([@B45]).

During extracellular or/and highly pro-inflammatory bacterial infection, the pathogen mostly neutralizes or eliminates the immune response effectors. In this context, the production of IL-10 modulates the immune response intensity and allows a successful bacterial clearance, without excessive host tissue damage. Although in some cases the absence of IL-10 makes the immune response more effective to clear the pathogen, the damage produced on host tissues is more severe and compromise host survival ([@B45]).

The strategies used by intracellular pathogens and/or bacteria that modulate the inflammatory response are different and mainly consist in their capacity to evade the immune system ([@B7]). In this condition, the production of IL-10 during the infective cycle of these bacteria helps them to evade the immune response and to disseminate within the host, seriously impairing host survival.

The studies performed so far that evaluate the role of IL-10 during bacterial infections have been performed using antibiotic susceptible bacteria. The conclusions reached in these reports cannot be translated to MDR-bacteria. Recent data have described that the immune response against antibiotic susceptible and MDR strains of the same bacterial specie may be remarkably different ([@B11]; [@B54]). Therefore, it raises two major questions about infections caused by MDR-bacteria. First: is the available data accurate enough to predict the role of immune effectors, such as anti-inflammatory cytokines, during MDR bacterial infections? And second: is it possible to develop new therapies against MDR bacteria with the current knowledge? To date, there are not enough data available to certainly answer both of these questions. However, in the last years increased efforts have made possible to understand better the role of some immune components in the response against different MDR bacteria.

In this mini-review, we will discuss whether the role of IL-10 during infections caused by major antibiotic susceptible bacteria applies to major MDR-bacterial infections. Next, we will analyze whether MDR-bacteria induce a differential production of IL-10 as compared to non-MDR bacteria, to finally discuss about the possible mechanisms that may explain this difference.

The Opposing Role of Il-10 During Multi-Drug Resistant Bacterial Infection
==========================================================================

Carbapenem-resistant *Acinetobacter baumannii* (*A. baumannii*) is an opportunistic, aerobic, Gram-negative, and extracellular bacteria classified as a critical pathogen by the WHO ([@B50]). *A. baumannii* is able to evade neutrophil mediated killing, including neutrophil extracellular traps (NETs) degradation ([@B27]) or uptake inhibition after adherence ([@B27]). This bacterium is commonly associated to primary health care facilities, causing skin infections, pneumonia, urinary tract infections and sepsis, mostly in immunocompromised patients ([@B34]; [@B23]).

One study demonstrated that during *A. baumannii* pneumonia, MDR *A. baumannii* virulence varies significantly as compared to non-MDR-*A. baumannii* ([@B11]). Importantly, the production of IL-10 in the lungs was positively correlated with host survival ([@B11]). Another report supported this observation ([@B41]). That report evaluated the role of receptor for advanced glycation end products (RAGE) during an *A. baumannii* infection. RAGE^-/-^ mice are more resistant to a pneumonia caused by non-MDR *A. baumannii* ([@B41]). The elevated survival rate displayed by RAGE^-/-^ mice is dependent on IL-10. Given that the neutralization of this cytokine reversed the resistant phenotype observed in these mice, and at the same time the administration of recombinant IL-10 improves host survival of susceptible wild type (WT) mice ([@B41]).

Carbapenem-resistant *Pseudomonas aeruginosa* (*P. aeruginosa*) is another bacterium classified in the critical group ([@B50]). *P. aeruginosa* is a Gram-negative opportunistic pathogenic bacterium able to causes chronic respiratory tract infections in patients with cystic fibrosis and in patients with compromised immune system ([@B18]). Due to the importance of *P. aeruginosa*, since long time ago scientists have started to use clinical isolates to study host-pathogen interaction, specifically ampicillin resistant strains ([@B9], [@B10]; [@B44]; [@B47]). A recent study analyzed cytokine production, cellular recruitment and bacterial clearance during the first 12 h during an intraperitoneal infection with four MDR isolates, three non-MDR isolates and two reference strains of *P. aeruginosa* in mice ([@B20]). MDR isolates induced a stronger immune response able to clear more efficiently the infective bacteria at 12 hpi ([@B20]). These data help to understand the differences of virulence and pathogenicity between MDR and not-MDR strains. However, given that the infection route was intraperitoneally and not intranasal, we cannot conclude whether the production of IL-10 is beneficial or detrimental during pneumonia caused by MDR *P. aeruginosa* in this particular experiment. Despite that, all the evidences show that IL-10 production protects the host during *P. aeruginosa*.

Both Carbapenem-resistant and 3^rd^ generation of cephalosporin resistant *Enterobacteriaceae* have also been categorized in the critical group ([@B50]). Within this group are included *Klebsiella pneumonia*, *Escherichia coli*, *Enterobacter* spp., *Serratia* spp., *Proteus* spp., *Providencia* spp. and *Morganella* spp. Most of the studies performed on these bacteria are epidemiological ([@B36]; [@B48]), genetic ([@B12]; [@B48]), or have been focused to understand the mechanisms involved in the acquisition of antibiotic resistance ([@B17]; [@B14]). However, few studies have been focused in the analysis of host-pathogen interaction with MDR-strains. Regarding to that these reports describe the immune response against carbapenem-resistant *K. pneumoniae* (CRKP) ([@B53]; [@B54]; [@B1]). These studies showed that CRKP isolates are less virulent ([@B53]; [@B54]) than antibiotic susceptible *K. pneumoniae* strains, but resistant to neutrophil-mediated clearance ([@B53]; [@B1]; [@B31]). CRKP showed to be highly susceptible to human serum ([@B42]; [@B13]) and the anti-capsule antibodies generation helped to innate cells to clear this pathogen *in vivo* ([@B32]). Another important characteristic of CRKP is the primary role of monocytes in the pathogenesis caused by this bacterium. For monocytes, at least two different roles have been described during CRKP infection: some of the monocytes recruited to the lungs are Monocytic Myeloid-derived cells (M-MDSCs) ([@B1]) probably able to establish an anti-inflammatory environment, aiding CRKP to evade the immune response. On the other hand, inflammatory monocytes are essential to phagocyte and kill CRKP as well as to activate ILC3s and Th~17~ response ([@B55]).

*Mycobacterium tuberculosis* (*M. tuberculosis*) is another bacterium included in the critical WHO group. *M. tuberculosis* is a rod-shaped bacterium with a cell wall rich in lipids able to cause chronic and latent infections in the lung tissue ([@B19]; [@B4]). During non-MDR *M. tuberculosis* infections, IL-10 production by neutrophils is important for host survival ([@B45]). But there is not data available that describe the immunity and the role of IL-10 during MDR *M. tuberculosis* infection at molecular level.

Methicillin/Vancomycin-resistant *Staphylococcus aureus* and 3rd generation cephalosporin/fluoroquinolone-resistant *Neisseria gonorrhoeae (N. gonorrhoeae)* are the only WHO high priority bacterial species for which the role of IL-10 production has been described ([@B37]; [@B35]). *Staphylococcus aureus* is an extracellular Gram-positive bacterium able to cause serious lung ([@B29]) and skin infections ([@B30]). Most of host-pathogen interaction research has been done on Methicillin-resistant *S. aureus* (MRSA), and the result of this research is the identification of bacterial and host factors involved in MRSA infection ([@B44]; [@B35]).

During a MRSA (USA300) infection there is a rapid production of IL-10 ([@B35]). The contribution of this cytokine for host survival varies according the nature of the infection. During an acute systemic infection, the production of IL-10 by CD19^+^CDB220^+^ cells was required to control the bacterial dissemination and its production is associated with host survival ([@B35]). However, in a sub-cutaneous infection model, IL-10 produced mostly by MDSCs in the local wound impairs MRSA clearance, without affecting host survival ([@B35]). MRSA infects orthopedic devices. In this case, the production of IL-10 by MDSCs favors the biofilm formation on the surface of these devices inducing persistent infections that do not affect host mortality ([@B25], [@B24]).

*Neisseria gonorrhoeae* is an obligate Gram-negative human pathogen ([@B3]; [@B2]) causative of gonorrhea, a sexually transmitted disease ([@B3]; [@B2]). During an intra-vaginal *N. gonorrhoeae* infection, the neutralization of IL-10 through the administration of microspheres improved the clearance of *N. gonorrhoeae* and enhanced the polarization to a Th~1~ response ([@B37]). These findings suggest that the production of IL-10 is detrimental for the immunity against this bacterium ([@B37]).

Fluoroquinolone-resistant *Salmonella enterica* (*S. enterica)* is a pathogenic bacterium categorized in the high priority group with *S. aureus* and *N. gonerrhoeae* ([@B50]). *S. enterica* is a Gram-negative foodborne pathogenic bacterium ([@B33]). Similar to other bacteria, few host-pathogen interaction studies have been reported for MDR *Salmonella* and yet the role of IL-10 during MDR *Salmonella* infection remains unknown. However, we have recently reported the role of IL-10 during an infection with non-MDR-*Salmonella enterica* serovar Typhimurium ([@B49]). This report demonstrates that IL-10 produced mostly by T cells impairs *Salmonella* clearance and increases host mortality ([@B49]). Further research is needed to evaluate whether MDR-*S*. Typhimurium will differentially induce IL-10 production during infection.

Mdr and Non-Mdr Bacteria Induce Differential Il-10 Production During Infection
==============================================================================

In the previous section, we described that the production of IL-10 plays a critical role during MDR-bacterial infections. Similar to infections caused by non-MDR bacteria, the production of IL-10 may lead to a better or worse outcome depending of the infecting bacteria. Since the MDR-bacteria and non-MDR bacteria present different virulence, it is possible to hypothesize that MDR-bacteria induce differential amounts of IL-10 during infection. Indeed, several studies corroborate this hypothesis. For example, ICU patients infected with extensively drug-resistant (XDR) *P. aeruginosa* presented elevated amounts of IL-10 in blood, as compared to patients infected with non-MDR *P. aeruginosa* ([@B21]). Same result was obtained in a mouse model of *P. aeruginosa* pneumonia ([@B51]). Consistently, patients infected with MDR *M. tuberculosis* presented higher amounts of IL-10 in the serum, as compared to patients infected with non-MDR *M. tuberculosis* ([@B46]). However, another group did not find any difference in IL-10 production in patients infected with MDR or non-MDR *M. tuberculosis* ([@B15]). Moreover, during a *S. aureus* endocarditis model, rabbits infected with MRSA presented higher amounts of IL-10 as compared to those infected with Methicillin susceptible *S. aureus* in the serum ([@B52]).

All these data suggest that MDR-bacteria might induce more IL-10 production than non-MDR bacteria. The only exception was found in *A. baumannii* infection, where children infected either with MDR *A. baumannii* presented the same levels of IL-10 as compared with children infected with non-MDR *A. baumannii* ([@B16]).

The next question then is as to how MDR-bacteria induce higher levels of IL-10. It is well known that antibiotic resistance not only involves the acquisition of hydrolytic enzymes, but also includes changes in proteins structure or expression of genes involved in virulence such as porins, two-component systems and others ([@B6]). Polysaccharide capsule (**Figure [1A](#F1){ref-type="fig"}**), present in bacteria such as *K. pneumoniae, P. aeruginosa, A. baumannii, S. aureus*, among other bacteria, is an important determinant for antimicrobial peptides and Polymyxin B resistance ([@B38]). An increased ability to produce capsule may be an adaptation against antibiotics. Interestingly, capsule recognition by pattern recognition receptors (PRRs) triggers IL-10 production in myeloid cells ([@B45]). MgrB is an important regulator of gene expression in *K. pneumoniae*, deletion of *mgrB* increases the resistance to collistin and Polymyxin B by the remodeling of lipid A mediated by the PhoPQ system ([@B28]). This increased resistance is associated with increased virulence and reduced TNF-α production ([@B28]). Lipid A remodeling has also been observed in MDR *P. aeruginosa*, also dependent on the activity of the PhoPQ system ([@B5]; [@B34]). PmrAB, another two-component system, is also involved in LPS modification and promotes antibiotic resistance in *S. enterica* and *P. aeruginosa* ([@B22]; [@B5]). Similarly, *A. baumannii* resistance to Polymyxin B is mediated by mutations in *lpxA, lpxC* and *lpxD*. These mutations lead to the loss of LPS by altering the biosynthesis of the lipid A ([@B39]) and induce a weaker immune response. It is unknown whether LPS modification by MDR-bacteria leads to higher production of IL-10. This possibility is highly probable, given that LPS recognition by TLR4 induces IL-10 production in myeloid cells (**Figure [1B](#F1){ref-type="fig"}**) ([@B45]).

![Proposed mechanisms of enhanced IL-10 production during MDR-bacterial infections and antibiotic treatment. The increased IL-10 production during MDR-bacteria can possibly be a consequence of **(A)** an improved ability of bacteria to synthesize polysaccharide capsule or **(B)** modifications in LPS. **(C)** Clarithromycin and probably other antibiotics promote the recruitment of myeloid suppressor cells and IL-10 production.](fmicb-09-02047-g001){#F1}

Multi-drug resistant *N. gonorrhoeae* carries the *opa* gene ([@B26]). Opa inhibits the proliferation of CD4^+^ T cells and B cells in mice ([@B8]), increases the expression of PD-L1 and stimulates the production of IL-10 ([@B56]).

Even though the treatments against MDR bacteria are limited, they mostly consist of antibiotic administration. A recent report describe that Clarithromycin promotes the recruitment of anti-inflammatory myeloid cells able to produce IL-10, Arginase-1 and iNOS to the lung tissue and the spleen ([@B40]). The recruitment of these cells to the lung protects the host during pneumococcal pneumonia and in LPS endotoxin shock ([@B40]). It is unknown whether other antibiotics also induce the production of IL-10 or other anti-inflammatory mediators. This would be an interesting hypothesis to evaluate (**Figure [1C](#F1){ref-type="fig"}**).

Conclusion
==========

In the last years, increasing data support the idea that IL-10 production drives the development of a successful immune response during bacterial infection. However, whether IL-10 production is beneficial or not for host survival depends of the pathogen nature and the immune response associated to the infection ([@B45]).

The rapid emergence of MDR bacteria is a major concern and has pushed the research community to invest more efforts in studying these bacteria. Most of the research done on MDR bacteria has been focused on epidemiological and genetic characterization ([@B36]; [@B12]; [@B48]); and limited numbers of studies have been focused in the understanding of host-pathogen interaction. The most important reason for the existence of this gap is the high amount of data available regarding non-MDR strains and the assumption that virulence and pathogenicity of MDR and non-MDR bacteria are similar. Recent reports show that pathogenicity and virulence can be remarkably different between MDR and non-MDR strains ([@B11]; [@B53]; [@B54]).

The data discussed in this mini-review support the dual role of IL-10, previously described for non-MDR can also be found during MDR bacterial infection. For non-MDR bacterial infection IL-10 production is required for host survival during infections caused by extracellular and/or highly pro-inflammatory bacteria. Conversely, for MDR bacterial infection, IL-10 impairs host survival and bacterial clearance during intracellular and/or weak pro-inflammatory bacteria. During *A. baumannii* and MRSA infection, the production of IL-10 is required for host survival. Both bacteria have acquired different virulence factors that allow them to neutralize the host immune response at different stages. In this scenario, a hyperactive immune response may occur, being IL-10 essential to modulate the intensity of it (**Figure [1](#F1){ref-type="fig"}**, left panel).

As we discussed previously, most of the studies about host--pathogen interaction of *P. aeruginosa* has been done using ampicillin resistant strains. In this scenario the production of IL-10 seems to be required for host survival, however, whether these data can be translated to carbapenem-resistant *P. aeruginosa* is unknown and more studies need to be done.

*S. enterica* and *N. gonorrhoeae* are both intracellular pathogens, either way; IL-10 absence and/or neutralization improve the host immunity against these microbes and increase host survival (**Figure [2](#F2){ref-type="fig"}**, right panel). Overall, these data is consistent with our initial hypothesis.

![The opposing role of the anti-inflammatory effect of IL-10. During MDR bacterial infections, the suppressive role of IL-10 can lead into two different outcomes. **(Left)** Describes that during infections with extracellular and/or pro-inflammatory bacteria, the strong immune response will be essentially modulated by IL-10, allowing a slow clearance with limited host tissue damage, generating an equilibrium required for host survival. On the contrary, during infections with intracellular and/or anti-inflammatory bacteria **(right)**, the production of IL-10 together with the bacterial virulence strategies will shut down the immune response, impairing the bacterial clearance, facilitating the dissemination within the host and at the end, increasing the host mortality rate.](fmicb-09-02047-g002){#F2}

Carbapenem-resistant *K. pneumoniae* is a special case. *K. pneumoniae* is an extracellular bacterium that induces a weak pro-inflammatory response ([@B1]). Published data show that during non-MDR *K. pneumoniae* infection, IL-10 production facilitates bacterial dissemination and impairs host survival ([@B45]). Several reports show that the virulence and pathogenicity of MDR strains are reduced as compared to non-MDR strains ([@B53]; [@B54]; [@B1]). It is quite remarkable that even though CRKP doses typically used in mice studies are around 1 × 10^8^ CFUs/mice, WT C57BL/6J are highly resistant to these infections ([@B53]; [@B54]; [@B1]). These bacteria are also resistant to neutrophil-mediated clearance ([@B1]; [@B31]) and during CRKP there is a rapid peak of IL-10 production ([@B1]). Taking account all this data, we hypothesize that during CRKP infection IL-10 is a major immune response modulator required for host survival (**Figure [2](#F2){ref-type="fig"}**, left panel).

One of the most important concerns of this report is the lack of research regarding host--pathogen interaction on MDR bacteria. It is clear by the whole community that the golden age of antibiotics is over, however, the knowledge of how these bacteria have adapted to the host immune response and how we can improve it is very limited. Therefore, we believe that more research in host immunity and bacterial virulence is required to design new strategies to identify effective therapeutic targets or strategies.

Finally, it is quite interesting MDR-bacteria stimulates higher IL-10 production as compared with non-MDR bacteria. We believe that the differential production of IL-10 may be a consequence of the changed expression pattern of different virulence factors displayed by these bacteria. This fact could explain why in general these bacteria are less virulent and why higher bacterial dose are commonly used to study host--pathogen interaction in mice.
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